4.5 Article

Mislocalisation of TDP-43 to the cytoplasm causes cortical hyperexcitability and reduced excitatory neurotransmission in the motor cortex

期刊

JOURNAL OF NEUROCHEMISTRY
卷 157, 期 4, 页码 1300-1315

出版社

WILEY
DOI: 10.1111/jnc.15214

关键词

ALS; cortex; excitability; glutamate; hyperexcitability; mislocalisation; mouse model; TDP-43

资金

  1. Motor Neurone Disease Research Institute Australia
  2. Australian Research Council Discovery Early Career Fellowship [DE170101514]
  3. Tasmanian Masonic Medical Research Foundation
  4. Australian Research Council [DE170101514] Funding Source: Australian Research Council

向作者/读者索取更多资源

ALS is a chronic neurodegenerative disease characterized by mislocalisation of the TDP-43 protein from the nucleus to the cytoplasm. Research in mouse models indicates that mislocalised TDP-43 causes intrinsic hyperexcitability and synaptic dysfunction in motor cortex neurons.
Amyotrophic lateral sclerosis (ALS) is a chronic neurodegenerative disease pathologically characterised by mislocalisation of the RNA-binding protein TAR-DNA-binding protein 43 (TDP-43) from the nucleus to the cytoplasm. Changes to neuronal excitability and synapse dysfunction in the motor cortex are early pathological changes occurring in people with ALS and mouse models of disease. To investigate the effect of mislocalised TDP-43 on the function of motor cortex neurons we utilised mouse models that express either human wild-type (TDP-43(WT)) or nuclear localisation sequence-deficient TDP-43 (TDP-43(Delta NLS)) on an inducible promoter that enriches expression to forebrain neurons. Pathophysiology was investigated through immunohistochemistry and whole-cell patch-clamp electrophysiology. Thirty days expression of TDP-43(Delta NLS) in adult mice did not cause any changes in the number of CTIP2-positive neurons in the motor cortex. However, at this time-point, the expression of TDP-43(Delta NLS) drives intrinsic hyperexcitability in layer V excitatory neurons of the motor cortex. This hyperexcitability occurs concomitantly with a decrease in excitatory synaptic input to these cells and fluctuations in both directions of ionotropic glutamate receptors. This pathophysiology is not present with TDP-43(WT) expression, demonstrating that the localisation of TDP-43 to the cytoplasm is crucial for the altered excitability phenotype. This study has important implications for the mechanisms of toxicity of one of the most notorious proteins linked to ALS, TDP-43. We provide the first evidence that TDP-43 mislocalisation causes aberrant synaptic function and a hyperexcitability phenotype in the motor cortex, linking some of the earliest dysfunctions to arise in people with ALS to mislocalisation of TDP-43.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Neurosciences

Cytoplasmic Human TDP-43 Mislocalization Induces Widespread Dendritic Spine Loss in Mouse Upper Motor Neurons

Marcus S. Dyer, Adele Woodhouse, Catherine A. Blizzard

Summary: ALS is characterized by the destruction of upper- and lower motor neurons, with the mislocalization of TDP-43 protein potentially causing hyperexcitability of upper motor neurons in ALS patients. TDP-43 mislocalization is found to impact the formation and durability of excitatory synapses, leading to network dysfunction in ALS.

BRAIN SCIENCES (2021)

Article Neurosciences

miR-23a suppression accelerates functional decline in the rNLS8 mouse model of TDP-43 proteinopathy

Stavroula Tsitkanou, Paul A. Della Gatta, Gavin Abbott, Marita A. Wallace, Angus Lindsay, Frederico Gerlinger-Romero, Adam K. Walker, Victoria C. Foletta, Aaron P. Russell

Summary: Skeletal muscle dysfunction may contribute to the progression and severity of ALS. In an ALS mouse model, suppression of miR-23a accelerates disease progression.

NEUROBIOLOGY OF DISEASE (2022)

Review Neurosciences

TDP-43 pathology: From noxious assembly to therapeutic removal

Sean S. Keating, Rebecca San Gil, Molly E. Swanson, Emma L. Scotter, Adam K. Walker

Summary: Our understanding of amyotrophic lateral sclerosis and frontotemporal dementia has greatly improved since the discovery of TAR DNA-binding protein 43 (TDP-43) inclusions as the key pathology. Recent studies have provided insights into the function of TDP-43 and its dysfunction in these neurodegenerative diseases. The formation and aggregation of pathological TDP-43 species contribute to cellular dysfunction and toxicity, and various protein homeostasis mechanisms play a role in combating TDP-43 aggregation and promoting disease progression. Future therapeutic strategies targeting TDP-43 clearance show promise in treating these diseases.

PROGRESS IN NEUROBIOLOGY (2022)

Article Neurosciences

Impaired glymphatic function in the early stages of disease in a TDP-43 mouse model of amyotrophic lateral sclerosis

Akram Zamani, Adam K. Walker, Ben Rollo, Katie L. Ayers, Raysha Farah, Terence J. O'Brien, David K. Wright

Summary: This study found that the glymphatic system is impaired in the early stages of amyotrophic lateral sclerosis (ALS), leading to progressive neurodegeneration and disrupted glymphatic function. This suggests that the glymphatic system could be a potential therapeutic target for ALS treatment.

TRANSLATIONAL NEURODEGENERATION (2022)

Editorial Material Genetics & Heredity

Cryptic inclusions UNCover losses driving neurodegeneration

Adekunle T. Bademosi, Adam K. Walker

Summary: Loss of TDP-43 function can lead to the development of neurodegenerative diseases such as ALS and FTD. Recent studies have also found that this loss of function results in the inclusion of cryptic exons in certain mRNAs, shedding light on new disease mechanisms.

TRENDS IN GENETICS (2022)

Article Biochemistry & Molecular Biology

Aggregation-prone TDP-43 sequesters and drives pathological transitions of free nuclear TDP-43

Sean S. Keating, Adekunle T. Bademosi, Rebecca San Gil, Adam K. Walker

Summary: Aggregation of TDP-43 is the hallmark of neurodegenerative diseases, involving depletion, mislocalisation, and post-translational modification of normal nuclear TDP-43. Oxidative stress triggers liquid-liquid phase separation of TDP-43, while RNA-binding deficiency and acetylation mimicry lead to sequestration of normal nuclear TDP-43 into dynamic anisosomes. Nuclear or cytoplasmic aggregation-prone TDP-43 mutants form phosphorylated inclusions that immobilize and insolubilize endogenous TDP-43, indicating pathological transition. Overall, these findings highlight the importance of RNA-binding deficiency and post-translational modifications in driving TDP-43 aggregation and dysfunction in neurodegenerative diseases.

CELLULAR AND MOLECULAR LIFE SCIENCES (2023)

Article Biochemistry & Molecular Biology

Early activation of cellular stress and death pathways caused by cytoplasmic TDP-43 in the rNLS8 mouse model of ALS and FTD

Wei Luan, Amanda L. L. Wright, Heledd Brown-Wright, Sheng Le, Rebecca San Gil, Lidia Madrid San Martin, Karen Ling, Paymaan Jafar-Nejad, Frank Rigo, Adam K. K. Walker

Summary: TDP-43 pathology is a major characteristic of ALS and FTD. Activation of cell stress pathways may contribute to the dysfunction of TDP-43. In a transgenic mouse model, several integrated stress response effectors were upregulated before disease onset, followed by pro-apoptotic signaling after the onset of motor phenotypes. Suppression of Chop had no effect on TDP-43 pathology or disease phenotypes. Precise temporal modulation of cell stress and death pathways may protect against neurodegeneration in ALS and FTD.

MOLECULAR PSYCHIATRY (2023)

Article Clinical Neurology

Intranasal neuropeptide Y1 receptor antagonism improves motor deficits in symptomatic SOD1 ALS mice

Rosemary M. Clark, Courtney M. Clark, Katherine E. A. Lewis, Marcus S. Dyer, Jyoti A. Chuckowree, Joshua A. Hoyle, Catherine A. Blizzard, Tracey C. Dickson

Summary: Objective: The objective of this study was to investigate the therapeutic potential and role of neuropeptide Y (NPY) in amyotrophic lateral sclerosis (ALS). Methods: NPY expression in post-mortem motor cortex tissue of ALS patients and controls was quantified, and the effect of NPY on ALS cortical pathophysiology was examined using in vitro experiments. The impact of NPY on ALS disease trajectory was assessed through intranasal delivery of NPY and selective NPY receptor agonists and antagonists in ALS mouse models. Results: Increased NPY expression was observed in the motor cortex of ALS patients, and NPY was found to ameliorate ALS hyperexcitability in vitro. Intranasal delivery of NPY and NPY receptor modulation improved survival and motor deficits in ALS mice. Interpretation: These findings demonstrate the potential of non-invasive brain-targeted interventions in ALS and suggest NPY Y1R antagonism as a novel strategy to improve ALS motor function.

ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2023)

Article Neuroimaging

Early and progressive dysfunction revealed by in vivo neurite imaging in the rNLS8 TDP-43 mouse model of ALS

Akram Zamani, Adam K. Walker, Ben Rollo, Katie L. Ayers, Raysha Farah, Terence J. O. Brien, David K. Wright

Summary: This study investigates the potential of neurite orientation dispersion and density imaging and diffusion tensor imaging (DTI) in detecting microstructural changes in an experimental model of ALS. The results suggest that these advanced neuroimaging techniques can detect significant changes in the early stages of the disease, providing valuable insights into the pathophysiological progression of ALS and potentially aiding in early diagnosis.

NEUROIMAGE-CLINICAL (2022)

Article Biochemistry & Molecular Biology

Associations between liver function and cerebrospinal fluid biomarkers of Alzheimer's disease pathology in non-demented adults: The CABLE study

Pei-Yang Gao, Ya-Nan Ou, Yi-Ming Huang, Zhi-Bo Wang, Yan Fu, Ya-Hui Ma, Qiong-Yao Li, Li-Yun Ma, Rui-Ping Cui, Yin-Chu Mi, Lan Tan, Jin-Tai Yu

Summary: Liver function may play a role in the progression of Alzheimer's disease. The study found that as AD progressed, certain liver function markers increased while others decreased. The relationship between liver function and CSF AD biomarkers indicates a potential mediation effect on cognition.

JOURNAL OF NEUROCHEMISTRY (2024)